| 作者 Terry |
发表于 2021-10-13 00:00:00 |

|
Sorry, I ran out of credit faizer pharma dbol Investigators reported that the powder formulation inhaled through the company's "Dreamboat" device provided superior reductions in A1c levels, allowed more patients to reach blood glucose target levels and reduced postprandial glucose excursions with no significant difference in the incidence of severe hypoglycemia among Type 2 diabetes patients. In the Type 1 study, the therapy proved noninferior to insulin aspart for decreases in A1c levels, triggered fewer cases of hypoglycemia, significantly improved blood sugar levels and offered an advantage for spurring weight loss.
|
|